NCT02945449View on ClinicalTrials.gov

Safety of Wharton Jelly in Erectile Dysfunction

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 4, 2017

Primary Completion Date

October 15, 2018

Study Completion Date

November 30, 2018

Conditions
Erectile Dysfunction Associated With Type 2 Diabetes Mellitus
Interventions
BIOLOGICAL

Wharton Jelly Mesenchymal stem cells

Intracavernous injection of Wharton Jelly Mesenchymal stem cells.

Trial Locations (1)

11942

Cell Therapy Center, Amman

All Listed Sponsors
lead

Sophia Al-Adwan

OTHER

NCT02945449 - Safety of Wharton Jelly in Erectile Dysfunction | Biotech Hunter | Biotech Hunter